Abstract
BACKGROUND:
Staphylococcus hominis is an opportunistic pathogen that expresses surface proteins, which are adhesive proteins that play a major role in biofilm formation. Biofilm is a protective layer that provides S. hominis bacteria with greater antibiotic resistance and promotes its adherence to biomedical surfaces, facilitating its entry into the bloodstream.
OBJECTIVE:
This research aimed to investigate the activity of Salicylic Acid (SA) and its effect on the gene expression of biofilm genes (FnbA and FnbB genes).
METHODS:
A total of 150 blood specimens were collected from patients. The specimens were cultured in broth media of the BacT/ALERT® system and subcultured on blood and chocolate agar. Bacteria were detected using the VITEK2 system. FnbA and FnbB genes were detected using PCR. The broth microdilution method performed the minimum inhibitory concentration (MIC) of Salicylic acid (SA) on S. hominis isolates with both genes. Detection of the gene expression levels of FnbA and FnbB genes was assessed using Real-Time PCR(RT-PCR).
RESULTS:
The results showed that out of the 150 specimens collected, 35 were S. hominis. The detection of S. hominis bacteria was performed by PCR amplification of two genes FnbA and FnbB and showed 100% and 17.14% of isolates were positive for genes FnbA and FnbB, respectively. The expression of FnbA and FnbB genes was decreased in samples treated with SA compared with untreated ones.
CONCLUSION:
In conclusion, there is a significant impact of SA on the prevention of biofilm formation of S. hominis through the suppression of gene expression, specifically FnbA and FnbB. This could enhance susceptibility to antimicrobial treatments. However, more research is required to determine whether SA leads to the selection of resistant bacteria.
Introduction
Staphylococcus
hominis is a type of Coagulase-negative staphylococci (CoNS) bacteria of the genus Staphylococcus, consisting of Gram-positive, spherical cells in clusters [1]. It is found on the human skin as normal flora and is usually harmless; however, it can cause infections in people with abnormal and weak immune systems. It produces several proteases, lipases, and exoenzymes that possibly contribute to the persistence of coagulase-negative Staphylococci in the host and may cause tissue degradation. The formation of multilayered bacterial biofilms is a major factor in the pathogenesis of biomaterial-associated infections, which allow microorganisms to adhere to smooth plastic surfaces, colonizing catheters, pacemakers, and various prosthetic and tissue surfaces [2]. Therefore, S. hominis was one of the three most common isolates as nosocomial. Most frequently, these bacteria are recognized as potentially opportunistic pathogens that can infect the gastrointestinal tract, bones, and joints, endocarditis, surgical site infections, and bloodstream infections [3]. Typically, biofilms are microbial colonies that are surface-associated and encased in an extracellular polymeric substance (EPS) matrix. In addition to providing the protection offered by the matrix, bacteria in biofilms employ several survival strategies to evade host defense systems and antibiotics by staying dormant and hiding from them. Within biofilms, bacteria adapt to environmental anoxia and nutrient limitation by altering their metabolism, protein production, and gene expression, leading to decreased metabolism and cell division rates [4, 5]. The production of biofilms occurs in three steps: bacterial cell attachment to the surface, biofilm development, and dispersal of some bacteria from the mature biofilm to new potential infection sites in the host [6]. S. hominis is a common nosocomial that can occasionally cause severe infections [7, 8]. Because of the rise in the use of medical equipment, such as vascular grafts, prosthetic heart valves, invasive surgical procedures, intravenous catheters, and devices for treating joint disease, the coagulase-negative Staphylococcus hominis strain is a common pathogen implicated in bacteremia [9]. Staphylococcai are Gram-positive, facultatively anaerobic, non-motile, and non-spore-forming cocci [10]. This bacterium is positive for catalase and, under a microscope, has a smooth, slightly spherical shape, arranged in grape-like clusters [11]. The pathogenicity of S. hominis is typically recognized by hospital-acquired bacteremia caused by medical interventions [12]. This is due to the virulent ability of these bacteria to produce biofilms. Biofilm formation is the main reason for resistance to the host immune response and antibiotics [13, 14]. The biofilm is frequently associated with infection, which offers a favorable environment for bacterial colonization and can support complex biofilm flora containing many bacteria [15]. Staphylococci express many surface proteins, including fibronectin-binding Proteins A and B (FnBPA and FnBPB), which are adhesives from the MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) family. According to the definition of MSCRAMM, “Has Similarities in structure and function as well as a shared ligand-binding mechanism carried out by two nearby IgG-like folded domains”, and is applied to cell wall-anchored proteins [16]. Other biofilm-forming genes, such as IcaA and IcaB, encode the transmembrane protein, which is involved in the secretion and elongation of the growing polysaccharides of biofilms [17]. Salicylic acid (SA) has general considerations, including antibacterial role (Gram positive and Gram negative), increasing/decreasing efflux pumps, OMPs, upregulating antibiotic targets, and Anti-chlamydial activity at high doses [18]. Recent studies have shown the effect of SA on Staphylococcus species in biofilm formation, the expression of some virulence factors, and the Agr quorum sensing system, a key pathogenicity regulator that is essential to the spread of mature biofilms and aids in their transportation to new colonization sites. SA interferes with agr expression, which limits the dissemination of biofilms [19, 20]. Staphylococcus species adhere to fibronectin, fibrinogen, and elastin of the host by fibronectin-binding proteins A and B (FnBPA and FnBPB), which are encoded by two genes, fnbA and fnbB [21]. SA can form complexes with iron cations and impacts the expression of virulence factors in S. aureus. It has also been demonstrated that the formation of the S. aureus biofilm is inhibited by several iron-chelating molecules. In addition, SA can alter the metabolism and/or metabolic regulators thus changing the gene expression of the essential polysaccharides involved in biofilm formation. In Pseudomonas (Gram-negative bacteria), SA also significantly reduced biofilm production (
Materials and methods
Collection of specimens
The time frame between October 2022 and April 2023 was when the study specimens were collected. There were 150 clinical specimens collected from Bloodstream infections from hospitalized patients with symptoms and signs of bacteremia. Some patients are asymptomatic or have only mild fever, whereas some symptoms increase, such as shaking chills, tachypnea, hypotension, persistent fever, altered sensorium, and gastrointestinal symptoms (nausea, abdominal pain, vomiting, diarrhea) [23]. The patients ranged in age from newborns (3 days) to adults (up to 88 years) who were admitted to hospitals in Baghdad. Blood samples from distinct vein punctures are collected in the hospital’s aseptic laboratory. To the greatest extent feasible, blood was drawn simultaneously from two arms, greater or equal to 10 ml blood for adults and 1–5 ml for infants, using a sterile syringe and needle by venipuncture. The needle was changed and immediately transferred into BacT/ALERT® Plus Blood Culture Bottles [24].
The primers used in this research
The primers used in this research
Culture
After injecting the blood patient into culture bottles (broth media), it was incubated in a BacT/ALERT® system (BioMe’rieux, USA) at 37∘C for 5 days from the culture bottles, which were marked as a positive alarm in this incubation instrument. Subcultures were performed, and the specimen was streaked both aerobically and anaerobically on chocolate and blood agar media. For a full day, the plates were incubated at 37∘C. Gram staining, biochemical testing, and morphological characteristics of the subcultured colony were performed (Gram-positive coccus is found as pairs, less frequently as irregular, grape-like clusters tetrads, cells are coagulase-negative, catalase positive, exhibit facultatively anaerobic metabolism and able to use glucose oxidatively and fermentatively). The Vitek2 compact system was utilized, and molecular detection was used to verify the identity [25, 26].
Molecular detection of FnbA and FnbB genes
The sequences and sizes of amplicons for virulence genes FnbA and FnbB were verified using the BLAST program from the NCBI database, and the diagnosis was performed using conventional PCR and analyzed by gel electrophoresis techniques to identify the right size of the amplified DNA bands.
Primers
All primers were provided by Macrogen Company in lyophilized form, as shown in Table 1.
DNA extraction
DNA was extracted from the isolated S. homoinis using a purification method called the Genomic DNA Mini Kit (Geneaid, Taiwan), and the DNA was extracted using the bacterial protocol for Gram-positive. The genomic DNA extraction from S. hominis isolates was confirmed as bands by gel electrophoresis. The Nanodrop spectrophotometer was used to measure the concentration and purity of DNA. The DNA purity and integrity were determined by the ratio of absorbance at 260 and 280 nm. It is generally agreed upon that DNA is “pure” at a ratio of approximately (1.8). A significantly lower ratio (
PCR master mix
Using 25
PCR program
The PCR program to identify the FnbA gene of S.hominis isolates
The PCR program to identify the FnbA gene of S.hominis isolates
The PCR program to identify the FnbB gene of S.hominis isolates
RCR is technology used for amplifying DNA sequences, which is based on the principle of enzymatic replication of the nucleic acids. To detect the FnbA and FnbB genes of S. homoinis, PCR was performed in a thermal cycler (Applied Biosystem, 9902, Singapore) in accordance with the PCR program with some modifications. Optimization of PCR was accomplished after several trials (Tables 2, 3).
PCR product analysis
The analysis of PCR products of the FnbA, FnbB gene of S. hominis were performed on 1.5% agarose gel. PCR products were loaded directly. For the PCR product, 5
Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of antimicrobial agents that inhibit the growth of a microorganism after a period of incubation. The minimum inhibitory concentrations (MICs) of the products (Salicylic acid solutions) were measured using a Resazurin dye. MIC was determined for the six samples that contained both genes (FnbA, FnbB). The MIC was calculated using the microdilution technique (Microtiter Plate Assay) with Resazurin Dye (method using the oxidation-reduction colorimetric indicator resazurin), at doses ranging 1000 ug/ml [29, 30]. The bacterial inoculum for the test was produced by culturing a Staphylococcus hominis subculture in brain heart agar for 18–24 h at 37∘C. Wells without Aspirin were used as positive controls, whereas those without S. hominis were considered as negative controls. Following a 24-h incubation period at 37∘C, the wells were examined visually to check for growth. According to some studies, the minimum inhibitory concentration (MIC) of aspirin inhibits bacterial growth [30].
Quantitative MIC of Aspirin (Salicylic acid) [31]
Using the micropipette, Put 100 ul of the medium into all the wells. of a microtiter plate. Pipette 100ul of appropriate 1000 ug/ml of Salicylic acid solutions (prepared by adding 1000 ug/ml of Salicylic acid in 1 ml of 0.2 M dimethyl sulfoxide) through the wells within column 1 except raw A, which is used as a positive control. Utilize the micropipette set at 100 ul, and mix the product through column 1’s wells by sucking up and down from six to eight times. Avoid splashing. Take 100 ul out of column 1 and put it in column 2, Column 2 thus represents a twofold dilution of column 1, Transfer 100 ul from column 2 to column 3, Proceed as before, stopping at column 11. Throw away 100 ul from column 11 instead of putting it in column 12. With the smaller micropipette set to 10 ul, Add bacteria to every well except raw H (sterility control and blank for the plate scanner). The plates should be incubated at 37∘C temperature. After 24 hours of satisfactory growth, 20
RT-PCR component
RT-PCR master mix
The real-time PCR program
Gene expression of FnbA, FnbB, and
Statistical analysis was used to determine how various factors affect the study’s parameters using the Statistical Analysis System- SAS (2018). To make a significant comparison between means, the T-test was used. In this study, the chi-square test was used to compare the percentages (0.05 and 0.01 probability) [34].
RNA Extraction for S. hominis.
The RNA extraction was done by using TRIzol® Reagent (Cat. No. 15596026) provided by Thermo Scientific Company (USA), chloroform (Cat. No. 1024441000) provided by LiChrosolv (Germany) [35]. The concentration and purity of RNA were measured by Quantus fluorometer (Promega, USA), then converted to cDNA for analysis and calculation of the expression levels. The procedures include data analysis, qPCR amplification, and total RNA purification. The figure below illustrates the study’s experimental design and workflow (Fig. 1).
Schematic outlining the overall experimental design.
The Gel electrophoresis of PCR products of FnbA gene. Detection of FnbA gene (422 base pair) by gel electrophoresis technique, the gel was run at 100 volt for 60 minutes at room temperature using a 100-bp DNA ladder (M), the negative control (NC) 5 
The Gel electrophoresis of PCR products of FnbB gene. Detection of FnbB gene (495 base pair) by gel electrophoresis technique, the gel was run at 100 volt for 60 minutes at room temperature using a 100-bp DNA ladder (M), the negative control (NC) 5 
The results demonstrate that Staphylococcus hominis is one of the common bacteria isolated from patients’ blood in hospitals in Baghdad city. S. hominis treated with a subMIC of salicylic acid solution had lower gene expression for adhesion-encoding genes (FnbA and FnbB genes) than those untreated.
Isolation and identification
A total of 150 clinical specimens isolated from blood were collected and cultured. The results included 35 (28.45%) specimens of blood that were subjected to typical biochemical tests and characteristics of morphology that are specific to coagulase-negative Staphylococcus hominis, whereas the other 88 (71.55%) isolates belong to other species of staphylococci and other pathogenic bacteria. while 27 clinical specimens showed no growth. In this study, 67 (54.47%) patients were females, whereas 56 (45.52%) were men. Patients’ ages for the study were between newborns (3 days) and adults (up to 88 years) for both genders. In a similar study, most pathogens isolated from blood cultures were Coagulase-negative Staphylococcus bacteria 60 (30.77%) [36], While in another study Coagulase-negative Staphylococcus bacteria in blood culture were 16 (10.09%) [37].
Fold change of FnbA gene expression in Staphylococcus hominis treated and untreated with salicylic acid
Fold change of FnbA gene expression in Staphylococcus hominis treated and untreated with salicylic acid
The fold change compared to the control group (untreated),
Fold change of FnbB gene expression in Staphylococcus hominis treated and untreated with salicylic acid
The fold change compared to the control group (untreated),
MICs of Aspirin (Salicylic acid) by ug/ml. MIC and sub-MIC determine of SA solution, serially diluted twofold from (500–0.48 
Gene Expression of FnbA gene of S. hominis with and without salicylic acid using RT-PCR technique. CT cycle RT-PCR of FnbA gene befor and after treated with Salicylic Acid.
Gene Expression of FnbB gene of S. hominis with and without salicylic acid using RT-PCR technique. CT cycle RT-PCR of FnbB gene befor and after treated with Salicylic Acid.
DNA was amplified for these genes using PCR in a mono-plex pattern using specific primers. The amplification revealed a product of 422 bp (FnbA gene) and 495 bp (FnbB gene). The number of
The minimum inhibitory concentration (MICs) of Salicylic acid solution
The products were serially diluted twofold from (500
Gene Expression using the RT-PCR technique
For the FnbA gene, when using the sub-MIC values of salicylic acid with the isolates, it was found that the fold of gene expression was slightly elevated before treatment with salicylic acid, whereas the fold change of the isolates after treatment with salicylic acid was lower (0.27–0.48–0.78) (Table 7), (Fig. 5). The calculation of fold values was performed using the average of triplicates of the expression of each gene.
For the FnbB gene, when using the sub-MIC values of salicylic acid with the isolates, it was found that the fold of gene expression was slightly elevated before the treatment with salicylic acid, whereas the fold change of the isolates after treatment with salicylic acid was lower (0.55–0.11–0.11–0.73) (Table 8), (Fig. 6).
We concluded that the low gene expression of FnbA and FnbB genes of S. homoinis isolates. Salicylic acid showed an antibacterial effect and could be important for the advancement of antibacterial agents against S. homoinis, particularly in multidrug-resistant isolates. In [15], SA led to decreased expression of some fibronectin and fibrinogen-binding protein genes in Staphylococcus aureus.
The integrity of RNA during storage is one of the crucial issues that needs to be considered. and the gene expression procedure. Because RNA can be affected by degradation reactions, it is sensitive to oxidation outside the cell by mechanisms generally involving metallic ions, which also result from an atmospheric pollutant that rapidly reacts with RNA. To prevent degradation, RNA samples are generally stored frozen at
Conclusion
Molecular detection using the PCR technique showed (100%) of isolates possess the FnbA gene and (17.14%) FnbB gene. The findings showed that the gene expression levels of biofilm formation genes were lower in strains treated with sub-MICs of salicylic acid than in untreated strains. This decline in the expression of biofilm formation genes corresponds to previous results demonstrating that sub-MICs of Salicylic acid inhibit biofilm formation and bacterial growth. There was a significant difference in the expression of FnbA and FnbB genes in the SA-treated isolates compared with the untreated ** (
Footnotes
Acknowledgments
The authors gratefully acknowledge all the staff in the Institute of Genetic Engineering and Biotechnology/University of Baghdad and the Department of Bacteriology Laboratory in Medical City Hospitals, Baghdad, Iraq.
Conflict of interest
The authors affirm that they have no competing interests.
Author contributions
HAA and ZHA Conceptualisation; Interpretation or analysis of data; HAA: Formal analysis and investigation and Resources; ZHA: funding acquisition and supervision; HAA: Writing original draft preparation; ZHA: writing review and editing.
